Literature DB >> 189708

Prostaglandins E and F in endocrine diarrheagenic syndromes.

B M Jaffe, S Condon.   

Abstract

The role of prostaglandins in endocrine diarrheagenic syndromes was evaluated by measuring peripheral concentration of immunoreactive PGE and PGF in patients with non-endocrine diarrhea as well as those with the Zollinger-Ellison (Z-E) syndrome, MCT, carcinoid tumors and the WDHA syndrome. In 21 normals, PGE and PGF levels averaged 272 +/- 18 and 119 +/- 14 pg/ml, respectively. Twenty eight patients with diarrhea of non-endocrine origin (mainly inflammatory bowel disease) had levels indistinguishable from normal, i.e. 353 +/- 25 and 77 +/- 37 pg/ml, respectively. Among 29 patients with the Zollinger-Ellison syndrome (mean gastrin 6127 +/- 3267 pg/ml) only 2 had significantly elevated PGE levels; mean PGE levels, 382 +/- 32 pg/ml, were not significantly different from normal and did not correlate with either diarrhea or the serum gastrin concentration. In contrast, 18 of 22 patients with carcinoid tumors (mean blood serotonin concentration 1655 +/- 604 ng/ml; mean urinary excretion of 5 HIAA 66.8 +/- 16.7 mg/day) had elevated peripheral concentrations of PGE. The mean PGE level (1367 +/- 245 pg/ml) was significantly elevated (P less than 0.001). Nonetheless PGE levels did not correlate with diarrhea, blood concentrations of serotonin, or urinary indole excretion. MCT (mean serum calcitonin 24.5 +/- 6.3 ng/ml) was similarly associated with consistent (18/19) elevation in peripheral concentrations of PGE (mean 1922 +/- 541 pg/ml; P less than 0.001). Inthis syndrome, PGE levels were higher in patients with diarrhea and in those with markedly elevated serum thyrocalcitonin levels. Finally, 8 of 21 patients with the WDHA syndrome had increased levels of PGE. Although 13 of 17 patients had high levels of VIP (mean 8133 pg/ml), 2 patients had hyperprostaglandinemia in the face of normal peripheral concentrations of VIP. In one patient the serum PGE level was elevated prior to resection of the primary pancreatic neoplasm (9939 pg/ml) as well as the subsequent extirpation of a solitary hepatic metastasis (1063 pg/ml); following each procedure the diarrhea abated and the PGE level returned to normal. In none of these syndromes were mean PGF levels elevated. The study has documented hyperprostaglandinemia in some endocrine diarrheagenic syndromes and validated the usefullness of measurements of PGE in patients with unexplained diarrhea.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 189708      PMCID: PMC1345455          DOI: 10.1097/00000658-197610000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  66 in total

1.  Watery diarrhea associated with pancreatic islet cell carcinoma.

Authors:  M G Schmitt; K H Soergel; G T Hensley; W Y Chey
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

2.  Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.

Authors:  S I Said; G R Faloona
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

3.  Pancreatic cholera: benefical effects of treatment with streptozotocin.

Authors:  C R Kahn; A G Levy; J D Gardner; J V Miller; P Gorden; P S Schein
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

4.  [The vaso-active intestinal polypeptide in Verner-Morrison syndrome].

Authors:  F J Seif; P Sadowski; F Heni; R Fischer; S R Bloom; J M Polak
Journal:  Dtsch Med Wochenschr       Date:  1975-02-28       Impact factor: 0.628

5.  Intravenous infusion of prostaglandin E2 raises plasma calcium concentration in the rat.

Authors:  R B Franklin; A H Tashjian
Journal:  Endocrinology       Date:  1975-07       Impact factor: 4.736

6.  Radioimmunoassay of vasoactive intestinal peptide.

Authors:  A M Ebeid; P Murray; H Hirsch; R I Wesdorp; J E Fischer
Journal:  J Surg Res       Date:  1976-04       Impact factor: 2.192

7.  Cholera-like diarrhoea induced by glucagon plus gastrin.

Authors:  G O Barbezat; M I Grossman
Journal:  Lancet       Date:  1971-05-15       Impact factor: 79.321

Review 8.  Pancreatic cholera. Sudies on tumoral secretions and pathophysiology of diarrhea.

Authors:  J C Rambaud; R Modigliani; C Matuchansky; S Bloom; S Said; D Pessayre; J J Bernier
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

9.  Validation and application of a radioimmunoassay for serotonin.

Authors:  J M Kellum; B M Jaffe
Journal:  Gastroenterology       Date:  1976-04       Impact factor: 22.682

10.  The role of prostaglandin E in the hemodynamic response to aortic clamping and declamping.

Authors:  E A Rittenhouse; W Maixner; H W Knott; R W Barnes; B M Jaffe
Journal:  Surgery       Date:  1976-07       Impact factor: 3.982

View more
  14 in total

1.  Anaesthesia for the carcinoid syndrome: a report of nine cases.

Authors:  R Miller; A U Patel; R R Warner; I H Parnes
Journal:  Can Anaesth Soc J       Date:  1978-05

2.  The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.

Authors:  H Ahlman; A Dahlström; K Grönstad; L E Tisell; K Oberg; M J Zinner; B M Jaffe
Journal:  Ann Surg       Date:  1985-01       Impact factor: 12.969

Review 3.  The pathophysiology and clinical aspects of hypercalcemic disorders.

Authors:  D B Lee; E T Zawada; C R Kleeman
Journal:  West J Med       Date:  1978-10

4.  Gastroenteropancreatic endocrine tumors.

Authors:  C Weil
Journal:  Klin Wochenschr       Date:  1985-05-15

5.  Hypertrophic gastritis associated with increased gastric mucosal prostaglandin E2 concentrations in a patient with the carcinoid syndrome.

Authors:  E J Boyd; G Hulks; J S Thomas; K E McColl
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

6.  Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera.

Authors:  A Ruskoné; E René; J A Chayvialle; N Bonin; F Pignal; M Kremer; S Bonfils; J C Rambaud
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

7.  Zollinger-Ellison syndrome: special considerations.

Authors:  J D Hardy; P D Doolittle
Journal:  Ann Surg       Date:  1977-06       Impact factor: 12.969

8.  A new bioassay of VIP: results in watery diarrhoea syndrome.

Authors:  M C Laburthe; C M Dupont; J D Besson; M Rousset; G E Rosselin
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

Review 9.  Prostaglandins and serotonin: nonpeptide diarrheogenic hormones.

Authors:  B M Jaffe
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

10.  Mixed pancreatic apudoma with symptoms of excess vasoactive intestinal polypeptide and insulin: improvement of diarrhoea with metoclopramide.

Authors:  R G Long; M G Bryant; P M Yuille; J M Polak; S R Bloom
Journal:  Gut       Date:  1981-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.